Full Name
Cheng Ean Chee
Main Affiliation


Results 1-14 of 14 (Search time: 0.018 seconds).

Issue DateTitleAuthor(s)
11-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
215-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
312-Apr-2023Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal AdenocarcinomaDaniel V. T. Catenacci; Yoon-Koo Kang; Hope E. Uronis; Keun-Wook Lee; Matthew C. H. Ng ; Peter C. Enzinger; Se Hoon Park; Philip J. Gold; Jill Lacy; Howard S. Hochster; Sang Cheul Oh; Yeul Hong Kim; Kristen A. Marrone; Ronan J. Kelly; Rosalyn A. Juergens; Jong Gwang Kim; Thierry Alcindor; Sun Jin Sym; Eun-Kee Song; Cheng Ean Chee ; Yee Chao; Sunnie Kim; Do-Youn Oh; Jennifer Yen; Justin I. Odegaard; Errin Lagow; Daner Li; Jichao Sun; Patrick Kaminker; Paul A. Moore; Minori Koshiji Rosales; Haeseong Park
416-Feb-2023Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsLoh, Jerold; Wu, Jiaxuan; Chieng, Jenny; Chan, Aurora; Yong, Wei-Peng ; Sundar, Raghav ; Lee, Soo-Chin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Goh, Boon-Cher ; Tai, Bee-Choo ; Chee, Cheng E 
51-Oct-2022Incident Cardiovascular Diseases among Survivors of High-Risk Stage II–III Colorectal Cancer: A Cluster-Wide Cohort StudyLee, SF; Yip, PL; Vellayappan, BA ; Chee, CE ; Wong, LC ; Wan, EYF; Chan, EWY; Lee, CF; Lee, FAS; Luque-Fernandez, MA
623-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
71-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
82019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
92-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
1015-Aug-2022Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitorsLim, Jhin Jieh ; Hooi, Lissa ; Dan, Yock Young ; Bonney, Glenn K ; Zhou, Lei ; Chow, Pierce K-H ; Chee, Cheng Ean ; Toh, Tan Boon ; Chow, Edward K-H 
1119-Sep-2023Reducing Chemotherapy Waiting Times in the Ambulatory Setting of a Tertiary Cancer Centre Using a Design Thinking ApproachJen, Wei-Ying ; Chan, Zhi Yao; Lee, Yee Mei ; Ng, Noel; Tan, Belinda; Teo, Constance; Wong, Yuet Peng; Chee, Cheng Ean ; Chee, Yen-Lin 
1215-Nov-2021Upregulation of C/EBPα inhibits suppressive activity of myeloid cells and potentiates antitumor response in mice and patients with cancerHashimoto, A; Sarker, D; Reebye, V; Jarvis, S; Sodergren, MH; Kossenkov, A; Sanseviero, E; Raulf, N; Vasara, J; Andrikakou, P; Meyer, T; Huang, KW; Plummer, R; Chee, CE ; Spalding, D; Pai, M; Khan, S; Pinato, DJ; Sharma, R; Basu, B; Palmer, D; Ma, YT; Evans, J; Habib, R; Martirosyan, A; Elasri, N; Reynaud, A; Rossi, JJ; Cobbold, M; Habib, NA; Gabrilovich, DI
132018Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyHeong V.; Syn N.L.; Lee X.W.; Sapari N.S. ; Koh X.Q.; Adam Isa Z.F. ; Sy Lim J.; Lim D. ; Pang B. ; Thian Y.L. ; Ng L.K. ; Wong A.L. ; Soo R.A. ; Yong W.P. ; Chee C.E. ; Lee S.-C., Goh B.-C. ; Soong R. ; Tan D.S.P. 
142020Whole exome sequencing of multi-regional biopsies from metastatic lesions to evaluate actionable truncal mutations using a single-pass percutaneous techniqueHeong V.; Tay D.; Goh S.E. ; Wee B. ; Tan T.Z. ; Soo R. ; Pang B. ; Lim D. ; Gopinathan A. ; Ow S. ; Chee C.E. ; Goh B.C. ; Lee S.C. ; Yong W.P. ; Wong A. ; Omar M.F.M. ; Soong R. ; Tan D.S.P.